Bioprobe Intl., Inc.
Country not established
- Devices
- 1
What Bioprobe Intl., Inc. makes
Bioprobe Intl., Inc. manufactures the Bioprobe Fluor Gentamicin assay, a diagnostic test designed to measure gentamicin concentrations in serum or plasma using fluorescence technology.
The company’s products fall under FDA Class II devices and are listed via 510(k) clearance in the United States. Bioprobe Intl., Inc. is based in the US.
Catalogue
Bioprobe Fluor Gentamicin In Serum Or Plasma Ref K852158
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Bioprobe Intl., Inc. have in the registry?
The registry currently lists 1 device for Bioprobe Intl., Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bioprobe Intl., Inc.'s devices?
Among its 1 most recently registered device, Bioprobe Intl., Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Bioprobe Intl., Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bioprobe Intl., Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bioprobe Intl., Inc. in the registry?
The most recently registered devices listed for Bioprobe Intl., Inc. include BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA.